uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted February 11, 2020

FTC Sues Two Companies Selling Bone Health and Joint Pain Supplements

On February 11, 2020, the Federal Trade Commission (FTC) announced that it sued two companies to stop them from continuing to make false claims about their bone and joint health products, Ostinol (ZyCal Bioceuticals) and StimTein (Excellent Marketing Results, Inc. (EMR)). EMR has agreed to settle the FTC charges and will pay $145,000, which may be used to refund customers. The FTC is proceeding with litigation against ZyCal and its president, James Scaffidi.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at